We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+13.69%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$53.1B
AUM Growth
+$6.76B
(+15%)
Cap. Flow
+$2.33B
Cap. Flow
% of AUM
4.39%
Top 10 Holdings %
Top 10 Hldgs %
14.65%
Holding
2,220
New
169
Increased
729
Reduced
1,033
Closed
165
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zscaler
ZS
|
+$222M |
| 2 |
Palantir
PLTR
|
+$221M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$213M |
| 4 |
FirstEnergy
FE
|
+$189M |
| 5 |
Broadcom
AVGO
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$383M |
| 2 |
Philip Morris
PM
|
+$280M |
| 3 |
Entergy
ETR
|
+$207M |
| 4 |
Paychex
PAYX
|
+$206M |
| 5 |
Gilead Sciences
GILD
|
+$201M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.81% |
| 2 | Healthcare | 14.57% |
| 3 | Financials | 13.43% |
| 4 | Industrials | 10.29% |
| 5 | Consumer Discretionary | 9.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
F5
FFIV
$23.2B
| $47.2M | 0.09% |
160,499
+42,597
| +36% | +$11.8M |
|
277
Chefs' Warehouse
CHEF
$4.54B
| $47.2M | 0.09% |
740,044
-30,824
| -4% | -$1.83M |
|
278
Yum! Brands
YUM
$41.1B
| $47.2M | 0.09% |
318,250
+313,351
| +6,396% | +$45.7M |
|
279
Home Depot
HD
$328B
| $46.9M | 0.09% |
127,885
+38,599
| +43% | +$14M |
|
280
Steris
STE
$22.7B
| $45.9M | 0.09% |
191,195
-137,115
| -42% | -$31.9M |
|
281
General Motors
GM
$75.6B
| $43.9M | 0.08% |
892,166
-56,473
| -6% | -$2.68M |
|
282
Kanzhun
BZ
$8.04B
| $43.8M | 0.08% |
2,455,286
-161,726
| -6% | -$2.72M |
|
283
Linde
LIN
$224B
| $43.6M | 0.08% |
92,890
+13,448
| +17% | +$6.14M |
|
284
Rollins
ROL
$17.3B
| $43.5M | 0.08% |
771,806
+714,235
| +1,241% | +$40.1M |
|
285
Fortune Brands Innovations
FBIN
$5.41B
| $43.5M | 0.08% |
844,342
-160,333
| -16% | -$8.39M |
|
286
EyePoint Inc
EYPT
$399M
| $43.3M | 0.08% |
4,599,450
+513,870
| +13% | +$3.55M |
|
287
Community Bank
CBU
$3.32B
| $43.1M | 0.08% |
757,625
-76,865
| -9% | -$4.27M |
|
288
FedEx
FDX
$78.4B
| $42.5M | 0.08% |
186,988
-35,727
| -16% | -$7.82M |
|
289
Colgate-Palmolive
CL
$72.5B
| $42.4M | 0.08% |
466,895
-133,279
| -22% | -$12.2M |
|
290
Oracle
ORCL
$438B
| $42.2M | 0.08% |
193,224
+111,372
| +136% | +$18M |
|
291
Littelfuse
LFUS
$10.7B
| $42.2M | 0.08% |
186,215
-43,245
| -19% | -$8.53M |
|
292
Domino's
DPZ
$11B
| $42M | 0.08% |
93,173
+24,363
| +35% | +$11.4M |
|
293
Trex
TREX
$4.69B
| $41.9M | 0.08% |
771,250
-144,677
| -16% | -$8.2M |
|
294
Interactive Brokers
IBKR
$43.7B
| $41.8M | 0.08% |
754,113
-108,683
| -13% | -$5.16M |
|
295
Telus
TU
$15.4B
| $41.6M | 0.08% |
2,588,678
+208,532
| +9% | +$3.23M |
|
296
Lockheed Martin
LMT
$131B
| $41.5M | 0.08% |
89,698
+53,618
| +149% | +$25.1M |
|
297
McDonald's
MCD
$184B
| $41.4M | 0.08% |
141,775
+64,757
| +84% | +$20M |
|
298
Xylem
XYL
$26.3B
| $40.1M | 0.08% |
310,264
-34,686
| -10% | -$4.2M |
|
299
Carvana
CVNA
$53.3B
| $39.8M | 0.08% |
591,190
+162,520
| +38% | +$8.91M |
|
300
Cintas
CTAS
$81.7B
| $39.4M | 0.07% |
176,769
-1,432
| -0.8% | -$308K |
|
Similar funds
Federated Hermes's Q2 2025 Portfolio in Review
As of Q2 2025, Federated Hermes held 2,220 positions worth $53.1B, up 15% from $46.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes deployed $2.33B of net new capital in Q2 2025, opening 169 new positions and adding to 729 existing holdings. Its largest new stake was Genuine Parts: 882,160 shares worth $107M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $383M trimmed.
- Federated Hermes's largest Q2 2025 buy was Genuine Parts: 882,160 shares worth $107M.
- Federated Hermes added most to Zscaler in Q2 2025, an estimated $222M increase.
- Federated Hermes's biggest Q2 2025 reduction was Bristol-Myers Squibb, cutting an estimated $383M.
- Federated Hermes fully exited Regulus Therapeutics in Q2 2025, selling an estimated $39.2M.
- Federated Hermes's ten largest holdings make up 15% of its $53.1B portfolio in Q2 2025.
- Federated Hermes opened 169 new positions and closed 165 in Q2 2025.
- Federated Hermes's portfolio value rose 15% quarter-over-quarter to $53.1B.
Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.